These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 29247465)

  • 21. Single-unit Activity in the in vitro Entorhinal Cortex During Carbachol-induced Field Oscillations.
    Chen LY; Lévesque M; Cataldi M; Avoli M
    Neuroscience; 2018 May; 379():1-12. PubMed ID: 29534974
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cannabinoids disrupt hippocampal sharp wave-ripples via inhibition of glutamate release.
    Maier N; Morris G; Schuchmann S; Korotkova T; Ponomarenko A; Böhm C; Wozny C; Schmitz D
    Hippocampus; 2012 Jun; 22(6):1350-62. PubMed ID: 21853502
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bidirectional Homeostatic Regulation of a Depression-Related Brain State by Gamma-Aminobutyric Acidergic Deficits and Ketamine Treatment.
    Ren Z; Pribiag H; Jefferson SJ; Shorey M; Fuchs T; Stellwagen D; Luscher B
    Biol Psychiatry; 2016 Sep; 80(6):457-468. PubMed ID: 27062563
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Distribution of type 1 cannabinoid receptor-expressing neurons in the septal-hypothalamic region of the mouse: colocalization with GABAergic and glutamatergic markers.
    Hrabovszky E; Wittmann G; Kalló I; Füzesi T; Fekete C; Liposits Z
    J Comp Neurol; 2012 Apr; 520(5):1005-20. PubMed ID: 21935941
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pre- and postsynaptic type-1 cannabinoid receptors control the alterations of glutamate transmission in experimental autoimmune encephalomyelitis.
    Musella A; Sepman H; Mandolesi G; Gentile A; Fresegna D; Haji N; Conrad A; Lutz B; Maccarrone M; Centonze D
    Neuropharmacology; 2014 Apr; 79():567-72. PubMed ID: 24440366
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glutamate and schizophrenia: phencyclidine, N-methyl-D-aspartate receptors, and dopamine-glutamate interactions.
    Javitt DC
    Int Rev Neurobiol; 2007; 78():69-108. PubMed ID: 17349858
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alterations in glutamatergic signaling in the brain of dopamine supersensitivity psychosis and non-supersensitivity psychosis model rats.
    Oda Y; Fujita Y; Oishi K; Nakata Y; Takase M; Niitsu T; Kanahara N; Shirayama Y; Hashimoto K; Iyo M
    Psychopharmacology (Berl); 2017 Oct; 234(20):3027-3036. PubMed ID: 28744562
    [TBL] [Abstract][Full Text] [Related]  

  • 28. GABAergic dysfunction in schizophrenia: new treatment strategies on the horizon.
    Guidotti A; Auta J; Davis JM; Dong E; Grayson DR; Veldic M; Zhang X; Costa E
    Psychopharmacology (Berl); 2005 Jul; 180(2):191-205. PubMed ID: 15864560
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronic Ketamine Reduces the Peak Frequency of Gamma Oscillations in Mouse Prefrontal Cortex Ex vivo.
    McNally JM; McCarley RW; Brown RE
    Front Psychiatry; 2013; 4():106. PubMed ID: 24062700
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Muscarinic cholinergic receptors modulate inhibitory synaptic rhythms in hippocampus and neocortex.
    Alger BE; Nagode DA; Tang AH
    Front Synaptic Neurosci; 2014; 6():18. PubMed ID: 25249974
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation of cannabinoid-1 receptors disrupts sensory gating and neuronal oscillation: relevance to schizophrenia.
    Hajós M; Hoffmann WE; Kocsis B
    Biol Psychiatry; 2008 Jun; 63(11):1075-83. PubMed ID: 18261715
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NMDA receptor activation enhances inhibitory GABAergic transmission onto hippocampal pyramidal neurons via presynaptic and postsynaptic mechanisms.
    Xue JG; Masuoka T; Gong XD; Chen KS; Yanagawa Y; Law SK; Konishi S
    J Neurophysiol; 2011 Jun; 105(6):2897-906. PubMed ID: 21471392
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential Control of Cocaine Self-Administration by GABAergic and Glutamatergic CB1 Cannabinoid Receptors.
    Martín-García E; Bourgoin L; Cathala A; Kasanetz F; Mondesir M; Gutiérrez-Rodriguez A; Reguero L; Fiancette JF; Grandes P; Spampinato U; Maldonado R; Piazza PV; Marsicano G; Deroche-Gamonet V
    Neuropsychopharmacology; 2016 Aug; 41(9):2192-205. PubMed ID: 26612422
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Major dorsoventral differences in the modulation of the local CA1 hippocampal network by NMDA, mGlu5, adenosine A2A and cannabinoid CB1 receptors.
    Kouvaros S; Papatheodoropoulos C
    Neuroscience; 2016 Mar; 317():47-64. PubMed ID: 26762803
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of Chronic Alcohol Exposure on the Modulation of Ischemia-Induced Glutamate Release via Cannabinoid Receptors in the Dorsal Hippocampus.
    Zheng L; Wu X; Dong X; Ding X; Song C
    Alcohol Clin Exp Res; 2015 Oct; 39(10):1908-16. PubMed ID: 26343919
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons.
    Katona I; Sperlágh B; Sík A; Käfalvi A; Vizi ES; Mackie K; Freund TF
    J Neurosci; 1999 Jun; 19(11):4544-58. PubMed ID: 10341254
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Spontaneous Gamma Activity in Schizophrenia.
    Hirano Y; Oribe N; Kanba S; Onitsuka T; Nestor PG; Spencer KM
    JAMA Psychiatry; 2015 Aug; 72(8):813-21. PubMed ID: 25587799
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cannabinoid receptor type 1 receptors on GABAergic vs. glutamatergic neurons differentially gate sex-dependent social interest in mice.
    Terzian AL; Micale V; Wotjak CT
    Eur J Neurosci; 2014 Jul; 40(1):2293-8. PubMed ID: 24698342
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endocannabinoid control of glutamate NMDA receptors: the therapeutic potential and consequences of dysfunction.
    Rodríguez-Muñoz M; Sánchez-Blázquez P; Merlos M; Garzón-Niño J
    Oncotarget; 2016 Aug; 7(34):55840-55862. PubMed ID: 27323834
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interleukin-1β alters the sensitivity of cannabinoid CB1 receptors controlling glutamate transmission in the striatum.
    De Chiara V; Motta C; Rossi S; Studer V; Barbieri F; Lauro D; Bernardi G; Centonze D
    Neuroscience; 2013 Oct; 250():232-9. PubMed ID: 23856068
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.